DOES A RADIOLABELED LIGAND BIND TO A HOMOGENEOUS POPULATION OF NONINTERACTING RECEPTOR-SITES

被引:32
作者
SWILLENS, S
WAELBROECK, M
CHAMPEIL, P
机构
[1] FREE UNIV BRUSSELS,CHIM BIOL & NUTR LAB,B-1070 BRUSSELS,BELGIUM
[2] CTR ETUD SACLAY,UNITE RECH 1290,F-91191 GIF SUR YVETTE,FRANCE
[3] CTR ETUD SACLAY,DEPT BIOL CELLULAIRE & MOLEC,BIOPHYS PROT & MEMBRANES SECT,F-91191 GIF SUR YVETTE,FRANCE
关键词
D O I
10.1016/S0165-6147(00)89007-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Receptor subtypes of pharmacological interest are often characterized by studies in which a particular radiolabelled ligand is competitively displaced from its binding sites, either by its unlabelled analogue (homologous displacement), or by different, unlabelled, ligands (heterologous displacement). In this article, Stephane Swillens, Magali Waelbroeck and Philippe Champeil emphasize the fact that a single homologous displacement curve is generally unable to reveal that the radioligand binds to a heterogeneous receptor population. Overlooking this heterogeneity may, in turn, dramatically affect interpretation of heterologous displacement curves displaying more than one receptor type far the unlabelled ligand: neither the binding affinities of the ligands for the different receptors, nor the proportion of these receptors, can be estimated reliably.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 8 条
  • [1] McGonigle, Neve, Molinoff, Mol. Pharmacol., 30, pp. 329-337, (1986)
  • [2] Cheng, Prusoff, Biochem. Pharmacol., 22, pp. 3099-3108, (1973)
  • [3] Boeynaems, Dumont, Outlines of Receptor Theory, (1980)
  • [4] Karlsson, Neil, Mol. Pharmacol., 35, pp. 59-66, (1989)
  • [5] Tolkovsky, Mol. Pharmacol., 22, pp. 648-656, (1982)
  • [6] Trifiletti, Lo, Snyder, Mol. Pharmacol., 26, pp. 228-240, (1984)
  • [7] Waelbroeck, Gillard, Robberecht, Christophe, Mol Pharmacol., 30, pp. 305-314, (1986)
  • [8] Burgisser, Lefkowitz, De Lean, Mol. Pharmacol., 19, pp. 509-512, (1981)